Hoʻopili ʻia ʻo Sympathetic blockade me ka botulinum toxin me ka hōʻoluʻolu ʻeha i ka maʻi ʻeha o ka ʻāina paʻakikī: haʻawina

South Korea: Ua hōʻike ʻia kahi noiʻi hou i ka lumbar sympathetic ganglion block me ka botulinum toxin type A i hoʻonui i ka mahana o ka wāwae no 3 mau mahina i nā maʻi me ka maʻi ʻeha o ka ʻāina paʻakikī, ʻoiai e hōʻemi ana i ka ʻeha.
Ua hoʻolālā ʻia kēia haʻawina e hoʻāʻo i ke kuhiakau e hoʻolōʻihi i ka botulinum toxin i ka lōʻihi o ka lumbar sympathetic blockade e like me ke ana ʻana e ka piʻi mau ʻana o ka mahana o ka ʻili. e nānā i nā hopena lapaʻau o lumbar sympathetic ganglion block i nā poʻe maʻi me ka maʻi ʻeha ʻāpana ʻāpana i mālama ʻia me ka botulinum toxin type A.
No ka hana ʻana i kēia, ua hana nā mea noiʻi i ka lumbar sympathetic ganglion block i nā poʻe maʻi me ka maʻi ʻehaʻeha o ka ʻāpana haʻahaʻa e hoʻohana ana i ka 75 IU o ka botulinum toxin type A (botulinum toxin group) a me kahi anesthetic kūloko (hui mana).
ʻO ka hopena mua ka hoʻololiʻana i ka likeʻole o ka mahana ma waena o ka sole i hoʻopaʻaʻia a me ka sole contralateral i ka 1 mahina ma hope o ka hanaʻana.
"Uaʻike mākou i ka hoʻokomoʻiaʻana o ka botulinum toxin type A i loko o ka lumbar sympathetic ganglia i hoʻonui i ka mahana o ka wāwae i hoʻopiliʻia i nā mahina 3 i hoʻohālikelikeʻia me nā anesthetics kūloko," i kākau ai nā mea kākau.Ua hui pū ʻia kēia me ka hōʻemi ʻana i ka ʻeha a me ka hoʻomaikaʻi ʻana i ke anuanu.
Yongjae Yoo, Chang-Soon Lee, Jungsoo Kim, Dongwon Jo, Jee Youn Moon;Botulinum toxin type A no ka lumbar sympathetic ganglion block in complex regional pain syndrome: kahi hoʻāʻo randomized.
Ua komo ʻo Medha Baranwal i ke kamaʻilio lāʻau lapaʻau ma 2018 ma ke ʻano he Luna Hoʻoponopono o ka ʻOihana Lapaʻau Kūkākūkā. Ua uhi ʻo ia i nā mea lapaʻau he nui e pili ana i ka ʻepekema cardiac, dentistry, diabetes and endoscopy, diagnostics, ENT, gastroenterology, neuroscience and radiology.


Ka manawa hoʻouna: Mar-16-2022